小窓モード

プレミアム

ログイン
設定

設定

「HIV-1」の共起表現一覧(1語右で並び替え)

該当件数 : 45



CX3CR1 also is a coreceptor for HIV-1, and some variations in this gene lead to incr
These include human immunodeficiency viruses ( HIV-1 and HIV-2) and simian immunodeficiency virus (
cells of the human genital epithelium binds to HIV-1 and subsequently internalizes it into Birbeck
resses structural analysis of the AIDS viruses HIV-1 and SIV, and the antibodies that neutralize th
receptor for the human immunodeficiency virus, HIV-1) and CD8 on T-cells interact with protein-tyro
t (scr2), or as a potential human repressor of HIV-1 and ILR-2 alpha promoter transcription (YC1).
It can be found in HIV-1 but not in HIV-2.
MCP-2 is a potent inhibitor of HIV-1 by virtue of its high-affinity binding to the
HIV-1 carries out reverse transcription, a process t
This is a solution RNA structure model of the HIV-1 dimerization initiation site in the kissing-lo
The HIV-1 DIS structure consists of a conserved hairpin
ncy virus type 1 dimerization initiation site ( HIV-1 DIS) is an RNA structure that is shown to prom
f Michigan determined that BanLec bound to the HIV-1 envelope protein gp120, which is high in sugar
change in a single gene (Trim-5alpha) prevents HIV-1 from replicating in monkeys.
s found to be an important cellular factor for HIV-1 gene expression and viral replication.
that is known to direct specific packaging of HIV-1 genomic RNA.
des, carbohydrates and viral proteins, such as HIV-1 gp120 and gp41.
intercellular adhesion molecule 3 (ICAM3) and HIV-1 gp120, and enhances HIV-1 infection of T cells
"Hit HIV-1 hard, but only when necessary", Mike Harringto
s a host defence to retroviral infection which HIV-1 has overcome by the acquisition of Vif.
cDNA is also produced by retroviruses (such as HIV-1, HIV-2, Simian Immunodeficiency Virus, etc.) w
A lectin (BanLec) from bananas inhibits HIV-1 in vitro
her antiretroviral agents for the treatment of HIV-1 infection in adults.
atment of human immunodeficiency virus type 1 ( HIV-1) infection in antiretroviral treatment-experie
d response to HAART during initial therapy for HIV-1 infection" (2007) Journal of Psychosomatic Res
Enfuvirtide is indicated for the treatment of HIV-1 infection, in combination therapy with other a
to free radicals, and inhibit the function of HIV-1 integrase.
5HN brings integrated HIV-1 out of latency but does not activate all T cel
HIV-1 progression can be delayed by using Aciclovir,
The structure of HIV-1 protease complexed with inhibitor BEA369 based
The structure of HIV-1 protease (green and cyan) complexed with a pol
It was found to inhibit HIV-1 replication in vitro and during Phase II clini
the nuclear export of many proteins including HIV-1 Rev, MAPK/ERK, and NF-κB/IκB, and it stabilize
Proposed HIV-1 RNase H mechanism
Within human immunodeficiency virus type 1 ( HIV-1), RNase H exists as a domain in the heterodime
The HIV-1 SD structure consists of a highly conserved 19
unodeficiency virus type 1 major splice donor ( HIV-1 SD) is an RNA structure that is shown to modul
nfection by targeting and crippling the sticky HIV-1 spike proteins.
bit the replication of the clinically isolated HIV-1 strain as well as the cultured strain in vitro
mple with the histone acetyltransferase TIP60 ( HIV-1 Tat interacting protein 60 kDa), which acetyla
eptors are required for internalization of the HIV-1 tat protein.
nevitable consequence of prolonged exposure of HIV-1 to antiretroviral therapy.
2 (or SDF-1) and, as with CCR5, is utilized by HIV-1 to gain entry into target cells.
a 2 year trial, 284 people progressed with the HIV-1, versus 324 who had not been treated with Acic
to be recruited by the Gag polyprotein during HIV-1 virus infection, and its incorporation into ne
                                                                                                   


こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する
英→日 日→英
こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する

©2024 GRAS Group, Inc.RSS